Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New dengue shot tested on seniors in major safety trial

NCT ID NCT06891950

Summary

This study is testing whether a dengue vaccine is safe and produces a strong immune response in older adults (ages 60-79) compared to middle-aged adults (40-59). Researchers will give the vaccine to about 1,000 healthy participants and track their antibody levels and any side effects for one year. The goal is to see if the vaccine works as well for seniors as it does for younger adults.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DENGUE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CWB 02 - Centro Médico São Francisco

    RECRUITING

    Curitiba, Paraná, 80810-050, Brazil

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • PET 01 - Hospital Escola da Universidade de Pelotas - HEUFPEL

    RECRUITING

    Pelotas, Rio Grande do Sul, 96040-010, Brazil

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • POA 01 - Centro de Pesquisa: Hospital São Lucas - PUCRS

    RECRUITING

    Porto Alegre, Rio Grande do Sul, 90610-000, Brazil

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • POA 02 - Associação Hospitalar Moinhos de Vento

    RECRUITING

    Porto Alegre, Rio Grande do Sul, 90560-032, Brazil

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • POA 05 - Núcleo de Pesquisa do Rio Grande do Sul

    RECRUITING

    Porto Alegre, Rio Grande do Sul, 90430-001, Brazil

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.